Boston, MA, United States of America

Jun Suzuki

This inventor holds 1 USPTO granted patent. Top assignee: Massachusetts Eye and Ear Infirmary. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jun Suzuki. Retrieved from https://idiyas.com/inventor/jun-suzuki-4v380ooi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Ocular Treatment by Jun Suzuki

Introduction

Jun Suzuki is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of ocular health, particularly in treating inflammatory disorders. His innovative approach has the potential to improve the quality of life for many individuals suffering from vision-related issues.

Latest Patents

Jun Suzuki holds a patent for "Methods for treating ocular inflammatory disorders." This patent outlines methods for treating conditions such as macular edema using an AMP kinase activator, specifically 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR). The method aims to reduce inflammation, thereby minimizing the loss of vision or visual function associated with these ocular disorders.

Career Highlights

Jun Suzuki is affiliated with the Massachusetts Eye and Ear Infirmary, where he continues to work on innovative solutions for ocular health. His research and development efforts have positioned him as a key figure in the field of ophthalmology.

Collaborations

Some of his notable coworkers include Demetrios Vavvas and Joan W. Miller, who contribute to the collaborative environment that fosters innovation in their research endeavors.

Conclusion

Jun Suzuki's work in developing methods for treating ocular inflammatory disorders showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of vision-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…